Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Clin Biochem. 2010 Apr;43(6):539-44. doi: 10.1016/j.clinbiochem.2009.12.014. Epub 2009 Dec 21.
Within the past decade, the use of biomarkers to detect myocardial injury in the emergency department (ED) has been given increasing prominence as evident by the numerous studies and guidelines documenting their use. This review details the scope of the clinical problem, the history of changes in the definition of myocardial infarction (MI) and the new approaches, as well as suggestions for using laboratory biomarkers in the early detection of MI in the ED.
在过去的十年中,生物标志物在急诊科(ED)检测心肌损伤的应用越来越受到重视,这一点可以从众多记录其应用的研究和指南中得到证明。本文详细介绍了临床问题的范围、心肌梗死(MI)定义的变化历史以及新方法,以及在 ED 中早期检测 MI 时使用实验室生物标志物的建议。